Medpace Holdings Inc (MEDP)
Working capital turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 2,108,550 | 1,883,940 | 1,519,300 | 1,145,160 | 926,439 |
Total current assets | US$ in thousands | 1,029,230 | 593,828 | 333,962 | 690,912 | 473,651 |
Total current liabilities | US$ in thousands | 1,104,550 | 925,131 | 803,470 | 557,217 | 440,110 |
Working capital turnover | — | — | — | 8.57 | 27.62 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $2,108,550K ÷ ($1,029,230K – $1,104,550K)
= —
The working capital turnover of Medpace Holdings Inc has shown a significant decline over the years. In 2020, the working capital turnover was 27.62, indicating that the company was able to generate revenue 27.62 times using its working capital. However, there was a substantial drop in this ratio in 2021 to 8.57, suggesting that the company's efficiency in utilizing its working capital to generate sales decreased.
The subsequent years, 2022, 2023, and 2024, are marked as "—," which indicates a lack of available data for analysis. It is essential for Medpace Holdings Inc to focus on effectively managing its working capital to ensure optimal utilization and efficiency in generating revenue. Further insight into the company's operations and financial health would be necessary to fully understand the trends in working capital turnover and make informed decisions regarding its financial management strategies.
Peer comparison
Dec 31, 2024